1. National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry. Issue 4 (December 2015) Authors: Ji, Linong; Tsai, Shih-Tzer; Lin, Jay; Bhambani, Sanjiv Journal: Diabetes therapy Issue: Volume 6:Issue 4(2015) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients. (12th August 2014) Authors: Amin, Alpesh; Jing, Yonghua; Trocio, Jeffrey; Lin, Jay; Lingohr-Smith, Melissa; Graham, John Journal: Journal of medical economics Issue: Volume 17:Number 11(2014) Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluating Costs of Biologic Drugs for the Treatment of Moderate-to-Severe Psoriasis in the United States. Issue 3 (July 2019) Authors: Feldman, Steven R.; Wu, Jashin J.; Armstrong, April W.; Lebwohl, Mark; Jacobson, Abby A.; Lingohr-Smith, Melissa; Lin, Jay Journal: Journal of psoriasis and psoriatic arthritis Issue: Volume 4:Issue 3(2019) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation. (2nd January 2016) Authors: Deitelzweig, Steve; Evans, Michael; Hillson, Eric; Trocio, Jeffrey; Bruno, Amanda; Tan, Wilson; Lingohr-Smith, Melissa; Singh, Prianka; Lin, Jay Journal: Current medical research and opinion Issue: Volume 32:Number 1(2016:Jan.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US. (2nd November 2019) Authors: Jabbour, Elias J.; Mendiola, Martin F.; Lingohr-Smith, Melissa; Lin, Jay; Makenbaeva, Dinara Journal: Journal of medical economics Issue: Volume 22:Number 11(2019) Page Start: 1113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US. (2nd November 2019) Authors: Amin, Alpesh; Deitelzweig, Steven; Bucior, Iwona; Lin, Jay; Lingohr-Smith, Melissa; Menges, Brandy; Neuman, W. Richey Journal: Journal of medical economics Issue: Volume 22:Number 11(2019) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status. (28th January 2019) Authors: Amin, Alpesh; Neuman, W. Richey; Lingohr-Smith, Melissa; Menges, Brandy; Lin, Jay Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 25(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants. (14th August 2019) Authors: Baker, Christine L.; Dhamane, Amol D.; Rajpura, Jigar; Mardekian, Jack; Dina, Oluwaseyi; Russ, Cristina; Rosenblatt, Lisa; Lingohr-Smith, Melissa; Lin, Jay Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 25(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Economic value of regular monitoring of response to treatment among US patients with chronic myeloid leukemia based on an economic model. (3rd October 2018) Authors: Jabbour, Elias J.; Siegartel, Lisa R.; Lin, Jay; Lingohr-Smith, Melissa; Menges, Brandy; Makenbaeva, Dinara Journal: Journal of medical economics Issue: Volume 21:Number 10(2018) Page Start: 1036 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety. (9th November 2020) Authors: Lingohr-Smith, Melissa; Deitelzweig, Chelsea; Lin, Grace; Lin, Jay Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗